Mesenchymal Stem Cells Isolated from Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway

Stem Cells

Volumn 33, Issue 8, 2015, Pages 2400-2415

  Hossain, Anwar ^a   Gumin, Joy ^a   Gao, Feng ^a   Figueroa, Javier ^a   Shinojima, Naoki ^a   Takezaki, Tatsuya ^a   Priebe, Waldemar ^a   Villarreal, Diana ^a   Kang, Seok Gu ^a   Joyce, Celine ^a   Sulman, Erik ^a   Wang, Qianghu ^a   Marini, Frank C ^a   Andreeff, Michael ^b   Colman, Howard ^c   Lang, Frederick F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Brain tumor; Glioblastoma; Glioma stem cells; Interleukin 6; Mesenchymal stem cells; STAT3

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; ENDOGLIN; GLYCOPROTEIN GP 130; HERMES ANTIGEN; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STAT3 PROTEIN; IL6 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CARCINOGENESIS; CARCINOGENICITY; CARTILAGE CELL; CELL CYCLE ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CHROMOSOME 10; CONTROLLED STUDY; COPY NUMBER VARIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE SEQUENCE; GLIOMA; GLIOMA STEM CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOCYTE; STEM CELL CULTURE; STEM CELL NICHE; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; CYTOKINE RECEPTOR GP130; FEMALE; GLIOMA; HUMANS; INTERLEUKIN-6; MALE; MESENCHYMAL STROMAL CELLS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84937631974     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2053     Document Type: Article

References (47)

1. Charles NA, Holland EC, Gilbertson R, et al., The brain tumor microenvironment. Glia 2011; 59: 1169-1180.
2. Lathia JD, Heddleston JM, Venere M, et al., Deadly teamwork: Neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 2011; 8: 482-485.
3. Singh SK, Hawkins C, Clarke ID, et al., Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
4. Bao S, Wu Q, McLendon RE, et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
5. Tso CL, Shintaku P, Chen J, et al., Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 2006; 4: 607-619.
6. Bianco P, Robey PG, Simmons PJ,. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313-319.
7. Dominici M, Le Blanc K, Mueller I, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
8. Crisan M, Casteilla L, Lehr L, et al., A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells 2008; 26: 2425-2433.
9. da Silva Meirelles L, Chagastelles PC, Nardi NB,. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
10. Kang SG, Shinojima N, Hossain A, et al., Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 2010; 67: 711-720.
11. Karow M, Sanchez R, Schichor C, et al., Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 2012; 11: 471-476.
12. Sneddon JB, Borowiak M, Melton DA,. Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme. Nature 2012; 491: 765-768.
13. Roodhart JM, Daenen LG, Stigter EC, et al., Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 2011; 20: 370-383.
14. Xu X, Zhang X, Wang S, et al., Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol 2011; 137: 495-504.
15. Cao H, Xu W, Qian H, et al., Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett 2009; 274: 61-71.
16. McLean K, Gong Y, Choi Y, et al., Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 2011; 121: 3206-3219.
17. Karnoub AE, Dash AB, Vo AP, et al., Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
18. Nakamizo A, Marini F, Amano T, et al., Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307-3318.
19. Shinojima N, Hossain A, Takezaki T, et al., TGF-beta mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Cancer Res 2013; 73: 2333-2344.
20. Yong RL, Shinojima N, Fueyo J, et al., Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res 2009; 69: 8932-8940.
21. Pittenger MF, Mackay AM, Beck SC, et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
22. Xi R, Hadjipanayis AG, Luquette LJ, et al., Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc Natl Acad Sci USA 2011; 108: E1128-E1136.
23. Lal S, Lacroix M, Tofilon P, et al., An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 2000; 92: 326-333.
24. Daneman R, Zhou L, Kebede AA, et al., Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010; 468: 562-566.
25. Dulauroy S, Di Carlo SE, Langa F, et al., Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-1270.
26. Steinhauser ML, Lee RT,. Pericyte progenitors at the crossroads between fibrosis and regeneration. Circ Res 2013; 112: 230-232.
27. Singh SK, Clarke ID, Terasaki M, et al., Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
28. Phillips HS, Kharbanda S, Chen R, et al., Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-173.
29. Wang R, Chadalavada K, Wilshire J, et al., Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468: 829-833.
30. Fomchenko EI, Dougherty JD, Helmy KY, et al., Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. PLoS One 2011; 6: e20605.
31. Prestegarden L, Svendsen A, Wang J, et al., Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res 2010; 70: 4274-4279.
32. Verhaak RG, Hoadley KA, Purdom E, et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98-110.
33. Carro MS, Lim WK, Alvarez MJ, et al., The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010; 463: 318-325.
34. Hirai H, Karian P, Kikyo N,. Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J 2011; 438: 11-23.
35. Kishimoto T,. Interleukin-6: From basic science to medicine-40 years in immunology. Annu Rev Immunol 2005; 23: 1-21.
36. Niwa H, Ogawa K, Shimosato D, et al., A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009; 460: 118-122.
37. Iwamaru A, Szymanski S, Iwado E, et al., A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2007; 26: 2435-2444.
38. Hjelmeland AB, Lathia JD, Sathornsumetee S, et al., Twisted tango: Brain tumor neurovascular interactions. Nat Neurosci 2011; 14: 1375-1381.
39. Moinfar F, Man YG, Arnould L, et al., Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res 2000; 60: 2562-2566.
40. Ellsworth DL, Ellsworth RE, Liebman MN, et al., Genomic instability in histologically normal breast tissues: Implications for carcinogenesis. Lancet Oncol 2004; 5: 753-758.
41. Fukino K, Shen L, Patocs A, et al., Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007; 297: 2103-2111.
42. Calabrese C, Poppleton H, Kocak M, et al., A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
43. Ho IA, Toh HC, Ng WH, et al., Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 2013; 31: 146-155.
44. Rowan BG, Gimble JM, Sheng M, et al., Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS One 2014; 9: e89595.
45. Zhang XH, Jin X, Malladi S, et al., Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 2013; 154: 1060-1073.
46. Hall B, Dembinski J, Sasser AK, et al., Mesenchymal stem cells in cancer: Tfumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 2007; 86: 8-16.
47. Rolhion C, Penault-Llorca F, Kemeny JL, et al., Interleukin-6 overexpression as a marker of malignancy in human gliomas. J Neurosurg 2001; 94: 97-101.